Form 4 for YARW Yarrow Bioscience, Inc.
Accepted 2024-01-03 00:00:00 ET · period of report 2024-01-01 · accession 0001209191-24-000465 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-01-03 | 2024-01-02 | YARW | Domzalski David | Pres, CEO, Dir | F - Tax | $2.28 | -1,004 | 495.2K | -0.2% | -$2,289 |
| D | 2024-01-03 | 2024-01-01 | YARW | Domzalski David | Pres, CEO, Dir | A - Grant | $0.00 | +225.0K | 496.2K | +83% | $0 |
| D | 2024-01-03 | 2024-01-01 | YARW | Domzalski David | Pres, CEO, Dir | A - Grant | $0.00 | +225.0K | 225.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-02 | F | D | 1,004 | $2.28 | 495,164 | D | — | — | (F3) Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. |
| 2 | Common | Common Stock | 2024-01-01 | A | A | 225,000 | $0.00 | 496,168 | D | — | — | (F1) Grant to the Reporting Person of a restricted stock unit ("RSU") award. Each RSU represents a contingent right to receive one share of common stock of the Issuer. (F2) The shares underlying the RSU vest over a period of 4 years. 25% of the shares subject to the award will vest on March 31, 2025 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date. |
| 3 | Derivative | Stock Option (right to buy) | 2024-01-01 | A | A | 225,000 | $0.00 | 225,000 | D | $2.33 · — to 2033-12-31 | 225,000 Common Stock | (F4) The shares subject to the option vest over a period of 4 years. 25% of the shares subject to the option will vest on March 31, 2025 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date. |